Surgery Partners (SGRY) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.10
- EPS estimate
- $0.06
- EPS surprise
- +72.71%
- Revenue surprise
- +2.27%
- Revenue
- $848.9M
- Revenue estimate
- $830.0M
- Reported
- Aug 10, 2026
Surgery Partners reported Q2 2026 results on August 10, 2026. EPS was $0.10 against a $0.06 estimate, a beat of 72.71%. Revenue was $848.9 million, 2.27% above the $830.0 million consensus. Compared with Q2 2025, EPS fell about 41% from $0.17, while revenue rose 2.7% from $826.2 million.
Revenue has grown steadily, from $2.54 billion in 2022 to $3.31 billion in 2025, about 30% higher. Earnings have not followed. Annual EPS jumped from $0.13 in 2022 to $0.99 in 2023, eased to $0.94 in 2024 and roughly halved to $0.46 in 2025. The first half of 2026 brought $0.07 per share, including a $0.03 loss in Q1, against $0.21 a year earlier, on revenue up about 3.6%. Fourth quarters are usually the strongest: Q4 2023 and Q4 2024 each earned $0.44, the high in the table, and Q4 2025 set the revenue high at $885.0 million. Over the last 20 quarters, Surgery Partners beat the EPS estimate 12 times. The last two quarters were beats, after four straight misses through 2025.
Q3 results came out between November 2 and November 12 in each of the past five years, pointing to early or mid-November 2026 for the next report.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 10, 2026 | $0.06 | $0.10 | +72.71% | $848.9M | SEC |
| Q1 2026 | May 5, 2026 | −$0.12 | −$0.03 | +75.90% | $810.9M | SEC |
| Q4 2025 | Mar 2, 2026 | $0.30 | $0.12 | −60.55% | $885.0M | SEC |
| Q3 2025 | Nov 10, 2025 | $0.20 | $0.13 | −35.93% | $821.5M | SEC |
| Q2 2025 | Aug 5, 2025 | $0.18 | $0.17 | −3.68% | $826.2M | SEC |
| Q1 2025 | May 12, 2025 | $0.07 | $0.04 | −39.49% | $776.0M | SEC |
| Q4 2024 | Mar 3, 2025 | $0.38 | $0.44 | +17.05% | $864.4M | SEC |
| Q3 2024 | Nov 12, 2024 | $0.25 | $0.19 | −24.45% | $770.4M | SEC |
| Q2 2024 | Aug 6, 2024 | $0.20 | $0.21 | +5.26% | $762.1M | SEC |
| Q1 2024 | May 7, 2024 | $0.07 | $0.10 | +39.86% | $717.4M | SEC |
| Q4 2023 | Feb 26, 2024 | $0.38 | $0.44 | +16.22% | $735.4M | SEC |
| Q3 2023 | Nov 7, 2023 | $0.14 | $0.19 | +32.77% | $674.1M | SEC |
| Q2 2023 | Aug 1, 2023 | $0.08 | $0.28 | +246.11% | $667.6M | SEC |
| Q1 2023 | May 1, 2023 | $0.00 | $0.08 | +2062.16% | $666.2M | SEC |
| Q4 2022 | Mar 1, 2023 | $0.20 | $0.27 | +32.87% | $707.1M | SEC |
| Q3 2022 | Nov 8, 2022 | $0.05 | −$0.02 | −143.76% | $620.6M | SEC |
| Q2 2022 | Aug 2, 2022 | −$0.02 | −$0.03 | −54.64% | $615.4M | SEC |
| Q1 2022 | May 3, 2022 | −$0.07 | −$0.09 | −26.94% | $596.2M | SEC |
| Q4 2021 | Feb 28, 2022 | $0.19 | $0.23 | +18.68% | $610.2M | SEC |
| Q3 2021 | Nov 2, 2021 | −$0.06 | −$0.05 | +15.68% | $559.2M | SEC |
Quarterly revenue
Frequently asked questions
When did Surgery Partners (SGRY) last report earnings?
Surgery Partners last reported on Aug 10, 2026, covering fiscal Q2 2026.
Did SGRY beat earnings estimates?
Yes. Surgery Partners reported EPS of $0.10 for Q2 2026 against a $0.06 estimate — a 72.71% beat.
How much revenue did SGRY report last quarter?
Surgery Partners reported $848.9M in revenue for Q2 2026, against a consensus estimate of $830.0M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.